1. Home
  2. ACIU vs BLZE Comparison

ACIU vs BLZE Comparison

Compare ACIU & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.18

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$4.85

Market Cap

282.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIU
BLZE
Founded
2003
2007
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
213.3M
282.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
ACIU
BLZE
Price
$3.18
$4.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$10.00
$9.50
AVG Volume (30 Days)
1.4M
872.7K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,482,957.00
$141,859,000.00
Revenue This Year
N/A
$16.43
Revenue Next Year
$738.95
$11.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.73
52 Week Low
$1.43
$3.94
52 Week High
$4.00
$10.86

Technical Indicators

Market Signals
Indicator
ACIU
BLZE
Relative Strength Index (RSI) 54.73 40.05
Support Level $2.87 $4.44
Resistance Level $3.45 $5.09
Average True Range (ATR) 0.30 0.21
MACD 0.03 0.15
Stochastic Oscillator 50.79 61.19

Price Performance

Historical Comparison
ACIU
BLZE

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: